Literature DB >> 15004784

Detection of amyloid plaques in mouse models of Alzheimer's disease by magnetic resonance imaging.

Jiangyang Zhang1, Paul Yarowsky, Marcia N Gordon, Giovanni Di Carlo, Sanjay Munireddy, Peter C M van Zijl, Susumu Mori.   

Abstract

We performed three-dimensional, high-resolution magnetic resonance imaging (MRI) of fixed mouse brains to determine whether MRI can detect amyloid plaques in transgenic mouse models of Alzheimer's disease. Plaque-like structures in the cortex and hippocampus could be clearly identified in T2-weighted images with an image resolution of 46 microm x 72 microm x 72 microm. The locations of plaques were confirmed in coregistration studies comparing MR images with Congo red-stained histological results. This technique is quantitative, less labor-intensive compared to histology, and is free from artifacts related to sectioning process (deformation and missing tissues). It enabled us to study the distribution of plaques in the entire brain in 3D. The results of this study suggest that this method may be useful for assessing treatment efficacy in mouse models of Alzheimer's disease (AD). Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15004784     DOI: 10.1002/mrm.10730

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  23 in total

1.  Regional differences in MRI detection of amyloid plaques in AD transgenic mouse brain.

Authors:  T M Wengenack; D A Reyes; G L Curran; B J Borowski; J Lin; G M Preboske; S S Holasek; E J Gilles; R Chamberlain; M Marjanska; C R Jack; M Garwood; J F Poduslo
Journal:  Neuroimage       Date:  2010-08-20       Impact factor: 6.556

2.  Magnetic resonance imaging of amyloid plaques in transgenic mouse models of Alzheimer's disease.

Authors:  Ryan Chamberlain; Thomas M Wengenack; Joseph F Poduslo; Michael Garwood; Clifford R Jack
Journal:  Curr Med Imaging Rev       Date:  2011-02

3.  High-field MRI of brain cortical substructure based on signal phase.

Authors:  Jeff H Duyn; Peter van Gelderen; Tie-Qiang Li; Jacco A de Zwart; Alan P Koretsky; Masaki Fukunaga
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-22       Impact factor: 11.205

4.  Imaging readouts as biomarkers or surrogate parameters for the assessment of therapeutic interventions.

Authors:  Markus Rudin
Journal:  Eur Radiol       Date:  2007-03-06       Impact factor: 5.315

Review 5.  MRI in rodent models of brain disorders.

Authors:  Aleksandar Denic; Slobodan I Macura; Prasanna Mishra; Jeffrey D Gamez; Moses Rodriguez; Istvan Pirko
Journal:  Neurotherapeutics       Date:  2011-01       Impact factor: 7.620

6.  In vivo magnetic resonance microimaging of individual amyloid plaques in Alzheimer's transgenic mice.

Authors:  Clifford R Jack; Thomas M Wengenack; Denise A Reyes; Michael Garwood; Geoffrey L Curran; Bret J Borowski; Joseph Lin; Gregory M Preboske; Silvina S Holasek; Gregor Adriany; Joseph F Poduslo
Journal:  J Neurosci       Date:  2005-10-26       Impact factor: 6.167

7.  Automatic segmentation of amyloid plaques in MR images using unsupervised support vector machines.

Authors:  Gheorghe Iordanescu; Palamadai N Venkatasubramanian; Alice M Wyrwicz
Journal:  Magn Reson Med       Date:  2011-08-16       Impact factor: 4.668

8.  In vivo measurement of plaque burden in a mouse model of Alzheimer's disease.

Authors:  Arijitt Borthakur; Tamar Gur; Andrew J Wheaton; Matthew Corbo; John Q Trojanowski; Virginia M-Y Lee; Ravinder Reddy
Journal:  J Magn Reson Imaging       Date:  2006-11       Impact factor: 4.813

9.  SPION-enhanced magnetic resonance imaging of Alzheimer's disease plaques in AβPP/PS-1 transgenic mouse brain.

Authors:  Laurel O Sillerud; Nathan O Solberg; Ryan Chamberlain; Robert A Orlando; John E Heidrich; David C Brown; Christina I Brady; Thomas A Vander Jagt; Michael Garwood; David L Vander Jagt
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

10.  In vivo imaging biomarkers in mouse models of Alzheimer's disease: are we lost in translation or breaking through?

Authors:  Benoît Delatour; Stéphane Epelbaum; Alexandra Petiet; Marc Dhenain
Journal:  Int J Alzheimers Dis       Date:  2010-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.